Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Arikci Denis

17 indexed publications match this author name.

ORCID: Not found in stored metadata
OpenAlex: Not found in stored metadata

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Depression 7 Pharmacology 5 Observational Study 5 Receptor Pharmacology 5 Anxiety 4 Healthy Volunteers 3 Consciousness 2 Review Article 2 Addiction 2 Mechanism of Action 2 Animal Study 2 Spirituality 2

Journals

Drug and Alcohol Dependence 2 Frontiers in Psychiatry 1 Neuropsychopharmacology 1 SLEEPJ 1 Biological Psychiatry 1 EvidenzUpdate 1 Fundamental & clinical pharmacology 1 SLEEP 1

Publication history

Psilocybin-containing mushroom-assisted psychotherapy is associated with sustained psychological and somatic improvements: two case studies from JamaicaFrontiers in Psychiatry · 2026-07-29 Acute dose-dependent effects of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) compared with 3,4-methylenedioxymethamphetamine (MDMA) and psilocybin in a double-blind, placebo-controlled study in healthy participantsNeuropsychopharmacology · 2026-07-01 0408 Insomnia Severity Differences by Psilocybin, LSD, and DMT Use Status Among Young Adult Daily Cannabis Consumers in the Herbal Heart StudySLEEPJ · 2026-05-08 Acute Effects of 4-Bromo-2,5-Dimethoxyphenethylamine (2C-B) Compared With Psilocybin and MDMA in Healthy ParticipantsBiological Psychiatry · 2026-05-01 Psilocybin, Lp(a), CAC, Niere und Darmkrebs - Evidenz-Quickies KW12EvidenzUpdate · 2026-03-22 Psilocybin as Transformative Fast-Acting Antidepressant: Pharmacological Properties and Molecular Mechanisms.Fundamental & clinical pharmacology · 2025-08-01 0391 Racial/Ethnic Differences in Psychedelic Use and Sleep Satisfaction: Preliminary Findings from the Herbal Heart StudySLEEP · 2025-04-30 Prevalence of Psilocybin and Cannabis Concurrent Use During the COVID-19 Pandemic: An Analysis of the COVID-19 Cannabis Health StudyDrug and Alcohol Dependence · 2024-07-01 High Blood Pressure Among Psilocybin and Cannabis Consumers During the COVID-19 Pandemic: An Analysis of the COVID-19 Cannabis Health StudyDrug and Alcohol Dependence · 2024-07-01 Psilocybin, peyote, mescaline, and lysergic acid diethylamide (LSD) use in a nationally representative population by cancer history.Journal of Clinical Oncology · 2024-05-31 Investigation of the structure, stability, and relative solubility of psilocybin in water and pure organic solvents: A molecular simulation studyJournal of Molecular Liquids · 2023-11-07 Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2023-10-01 Attenuation of psilocybin mushroom effects during and after SSRI/SNRI antidepressant use.Journal of psychopharmacology (Oxford, England) · 2023-07-01 In vivo mapping of pharmacologically induced functional reorganization onto the human brain's neurotransmitter landscape.Science advances · 2023-06-16 Serotonergic antidepressant use is associated with weaker psilocybin effectsPsyArXiv · 2022-10-28 Case Report: Resolution of Rheumatoid Arthritis in a Patient Consuming Psilocybin MushroomsJournal of Healthcare · 2020-08-19 P.228 The polypharmacological profile of psilocybin and potential behavioural effects of very low dosesEuropean Neuropsychopharmacology · 2019-12-01

Author directory